Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...

Neurosurgeon and scientist Dr. Jandial joined us to discuss a major breakthrough in pain medication recently approved by the ...

Feb. 25, 2025 – The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with ...

Days afta di BBC Africa eye don publish di latest exposé about one pharmaceutical company for India wey don dey produce ...

Q2 2025 Earnings Call Transcript February 28, 2025 Silviu Itescu: Good morning, everybody. I’m Silviu Itescu. I’m the Chief ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The FDA has suspended Aveo Pharmaceuticals’ GMP certificate following a BBC exposé revealing the illegal manufacturing and export of addictive opioids to West Africa. The authority has also halted ...

Spark Biomedical, Inc. is a leading U.S.-based medical device developer, committed to unlocking the potential of bioelectronic medicine and bringing to market novel wearable neurostimulation treatment ...

The change in leadership comes shortly after Indivior warned that it is expecting a sharp decline in its revenues in 2025, ...

Anywhere from 2 million to 15 million people use kratom each year. While the substance does induce feelings of mild euphoria, ...

SB161 would require that non-opioid pain treatments that have FDA approval be included on this preferred drug list with coverage terms that are no more restrictive than those given to opioid pain ...